Drug Approval | April 21, 2022
Dr. Reddy's launch Posaconazole delayed-release tablets in the US
The tablets are available in 100 mg strength in bottle count sizes of 60
The tablets are available in 100 mg strength in bottle count sizes of 60
New kit enhances menu of FFPE solutions and allows oncology researchers to extract higher yields of concentrated DNA compared to traditional techniques
Researchers have developed a plasma-based disinfectant generated with the help of cold atmospheric pressure plasma (CAP) which could act as a green decontaminant for Covid-19
The launch is yet another first of its kind innovation in India
To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs
The life sciences and pharmaceutical sectors suffer from hard-to-source biological materials, which translates into high costs in research and development
The purpose of the study is to investigate safety and tolerability of SNIPR001 in healthy volunteers and to evaluate the effect of SNIPR001 on reducing E. coli colonization in the gut
Bionova Scientific’s process development capabilities are particularly highly regarded in the industry, and it has a rich track record regarding complex next-generation antibody drugs, which are typically challenging to manufacture
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Subscribe To Our Newsletter & Stay Updated
